National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN Volasertib Research Grant Opportunity – Submit by October 30, 2014
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN ORP Grant History
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources



Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
800.811.8480
www.vicc.org

Learn more about clinical trials at this NCCN Member Institution.

Profile

The Vanderbilt-Ingram Cancer Center, home to two Nobel laureates, is an international leader in the cancer field, striving always toward its mission to alleviate cancer death and suffering through pioneering research; innovative, patient-centered care; and evidence-based prevention, education and community activities

The center's work is based on core values of:

Innovation and discovery

Impact and translation

Relationships and collaboration

Service and compassion

Vanderbilt-Ingram is a National Cancer Institute-designated Comprehensive Cancer Center affiliated with Vanderbilt University and Medical Center in Nashville, Tenn., and the only such center in Tennessee that conducts research and offers treatment for all types of adult and pediatric cancers. Led by Jennifer Pietenpol, Ph.D., the Center includes some 300 Vanderbilt faculty members in seven research programs. Together, these researchers and physician-scientists generate more than $140 million annually in federally funded research support. The Center currently ranks among the top 10 centers in both total grant support and the number of grants awarded annually by the National Cancer Institute. Vanderbilt is consistently listed by US News & World Report among the nation's best hospitals for cancer care. Vanderbilt Medical Center is the only hospital in the region to be awarded Magnet Nursing Services Recognition from the American Nurses Credentialing Center.

Vanderbilt-Ingram's clinical enterprise offers access to some of the nation's foremost experts in cancer clinical care delivered with a multi-disciplinary approach. The Center's 150 clinicians see more than 4,000 new cancer patients each year. Particular strengths include colorectal, breast, lung, head and neck, neurologic, prostate and renal cancers; melanoma, sarcomas; leukemias, lymphomas and myelomas; survivorship and post-cancer wellness; and clinical trials. Clinical trials are also available in more than a dozen locations in five states through the Vanderbilt-Ingram Cancer Center Affiliate Network.

A comprehensive survivorship program is being developed at Vanderbilt to focus on the long-term physical, emotional and practical issues facing cancer survivors and family members. This clinic, to be initially located within the Henry-Joyce Cancer Clinic in early 2009, will provide services for all cancer survivors, regardless of type of cancer, age at diagnosis, and where they received their cancer treatment. REACH for Survivorship also will provide access to research to improve cancer survival and quality of that survivorship; patient and health care provider education; patient advocacy; and access to wellness and fitness programs.

Known for its focus on translational research and team science, Vanderbilt-Ingram has been awarded numerous multi-investigator grants involving researchers from a wide variety of disciplines. These include Specialized Programs of Research Excellence in breast, gastrointestinal and lung cancers; a Molecular Signatures of Lung Cancer grant; a Minority Partnership grant with Meharry Medical College, a historically black medical school dedicated to addressing health disparities and the needs of the underserved; a Clinical Proteomic Technology Assessment for Cancer grant. The Center's team in population-based science and control focus on epidemiologic studies to better understand and address the causes of cancer, through large cohorts including the Southern Community Cohort Study of 90,000 residents of the Southeastern United States, two-thirds of them African American; large cohorts of men and women based in Shanghai, and other large cohorts in Denmark.

The Center's work is supported by a renowned biomedical informatics infrastructure at Vanderbilt Medical Center, which also holds an NIH Clinical and Translational Science Award (CTSA) from the National Institutes of Health, designed to provide the infrastructure and resources needed to move discoveries quickly from the laboratory into clinical care.

General public and referring physicians/health care professionals:

800.811.8480

Searchable database of clinicians and researchers: www.vicc.org and click on "Find a Doctor"

Clinical trials information

Visit www.vicc.org and click on "Clinical Trials" or call 800.811.8480 or visit NCCN.org.